feed,title,long_url,short_url
Benzinga,Amgen Touts Positive Data From Soliris-Based Biosimilar For Rare Blood Disorder,https://benzinga.com/general/biotech/22/08/28603005/amgen-touts-positive-data-from-soliris-based-biosimilar-for-rare-blood-disorder,https://bit.ly/3A9YWR6
Benzinga,JD.com Shares Are Moving Higher After Q2 Earnings: Here's Why,https://benzinga.com/news/earnings/22/08/28603461/jd-com-shares-are-moving-higher-after-q2-earnings-heres-why,https://bit.ly/3QMhtdr
